Even though p53 has been revealed to inhibit CCNB1 and CCNB2 in hepatocellular carcinoma [38], there is also evidence suggesting CCNB1 downregulated p53 expression by promoting its proteasome degradation in hepatocellular carcinoma [39, 40]. Here, CCNB2 is linked to hepatocellular carcinoma.